- Home
- NVCR vs NAC Comparison
NVCR vs NAC Comparison
Compare NVCR & NAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVCR | NAC |
|---|---|---|
| Founded | 2000 | 1998 |
| Country | Switzerland | France |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | 2015 | 1998 |
Fundamental Metrics
Financial Performance| Metric | NVCR | NAC |
|---|---|---|
| Price | $16.43 | $11.98 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $28.08 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 345.9K |
| Earning Date | 04-30-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.33% |
| EPS Growth | ★ 21.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $655,353,000.00 | N/A |
| Revenue This Year | $7.72 | N/A |
| Revenue Next Year | $6.74 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.28 | N/A |
| 52 Week Low | $9.82 | $10.90 |
| 52 Week High | $18.92 | $12.25 |
Technical Indicators
Market Signals| Indicator | NVCR | NAC |
|---|---|---|
| Relative Strength Index (RSI) | 47.06 | 41.77 |
| Support Level | $12.49 | $11.78 |
| Resistance Level | $18.48 | $12.01 |
| Average True Range (ATR) | 0.88 | 0.06 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 28.96 | 0.00 |
Price Performance
Historical ComparisonAbout NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.
About NAC Nuveen California Quality Municipal Income Fund
Nuveen California Quality Municipal Income Fund is a closed-end fixed income mutual fund that prominently invests in tax-exempt municipal bonds from California. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Arizona individual income taxes. Its portfolio mainly includes investment-grade municipal securities of California. The fund targets various sectors such as healthcare, utilities, transportation, and consumer staples.